Remission Through Early Monitored Insulin Therapy - Duration Month

Summary

REMIT-DM is a feasibility pilot study where participants will be recruited soon after their diagnosis of type 2 diabetes to be placed immediately on insulin therapy for maximum of four weeks with titrations of insulin guided by glucose levels and trends provided by a continuous glucose monitor (CGM), with the purpose of achieving diabetes remission.

Timeline

Start

2019-03-26

Primary completion

2020-07-31

Completion

2020-07-31

Drugs

Indications